Truist Securities Maintains Buy on Universal Technical, Lowers Price Target to $26
Truist Securities analyst Jasper Bibb maintains Universal Technical (NYSE:UTI) with a Buy and lowers the price target from $38 to $26.
Follow the latest Universal Technical Institute, Inc. (UTI) news and market headlines alongside the live UTI price. Stay informed on what's moving UTI.
Truist Securities analyst Jasper Bibb maintains Universal Technical (NYSE:UTI) with a Buy and lowers the price target from $38 to $26.
Universal Technical Institute (UTI) stock fell 8.48% after the vocational education company released disappointing fiscal 2026 earnings. While Q4 revenue of $235.9M slightly beat estimates, net income declined 4% to $18M. Management's guidance for fiscal 2027 projects net income of $0-$5M, well below analyst expectations of $0.73 per share, due to expansion expenses including four new campus openings under its 'North Star Strategy.'
Lake Street analyst Eric Martinuzzi maintains Universal Technical (NYSE:UTI) with a Buy and lowers the price target from $37 to $29.
B. Riley Securities analyst Raj Sharma maintains Universal Technical (NYSE:UTI) with a Buy and lowers the price target from $45 to $39.
Fiscal 2027 Financial Outlook"Looking ahead to fiscal 2027, we expect revenue between $925 million and $945 million, while new student starts are expected to grow 9% at the midpoint," continued Schuman. Our
Universal Technical (NYSE:UTI) is looking for FY2027 GAAP EPS of $0.00-$0.09 vs $0.74 analyst estimate. sees sales of $925.000 million-$945.000 million vs $968.876 million analyst estimate.
Universal Technical (NYSE:UTI) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.33 by 3.03 percent. This is a 5.88 percent decrease over earnings of $0.34 per share from
KinderCare Learning Companies reported a Q3 loss of $0.03 per share, missing consensus estimates of $0.01 loss, and posted revenues of $665.34 million, slightly below expectations. The company's stock has declined 50.5% year-to-date, significantly underperforming the S&P 500's 11.3% gain. With unfavorable estimate revisions, KLC received a Zacks Rank #4 (Sell) rating.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to UTI, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.